Drug · DIN 02552078
COMIRNATY
MULTIDOSE VIAL
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since September 24, 2024.
- Drug Identification Number (DIN)
- 02552078
- Company (DIN owner)
- Biontech Manufacturing GmbhMainz, Rheinland-Pfalz, Germany
- Schedule
- Schedule D
- Dosage form
- Suspension
- Route
- Intramuscular
- Therapeutic class (ATC)
- COVID-19, RNA-based vaccine J07BN01
- Class
- Human
- Record last updated
- October 9, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| *SARSCOV2 S-PROTEIN MRNA, 5'[M27,3'-OGPPP(M12'-O)APG], 3'POLYA+LINKER | 3 MCG | 0.3 ML |
Other DINs named COMIRNATY
- DIN 02541823 · Marketed
- DIN 02541858 · Marketed
- DIN 02552035 · Marketed
- DIN 02509210 · Cancelled Post Market
- DIN 02522454 · Cancelled Post Market
- DIN 02527863 · Cancelled Post Market
- DIN 02530325 · Cancelled Post Market